LSD, 5-HT (serotonin), and the evolution of a behavioral assay

Neuroscience and Biobehavioral Reviews

Volumn 27, Issue 8, 2004, Pages 693-701

  Appel, James B ^a   West, William B ^a   Buggy, James ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Drug discrimination; Lisuride (LHM); LSD; Rats; Serotonin (5 HT)

Indexed keywords

LYSERGIDE; QUIPAZINE; SEROTONIN; YOHIMBINE;

BEHAVIORAL RESEARCH; BRAIN REGION; BRAIN VENTRICLE; CONFERENCE PAPER; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; HALLUCINATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM;

EID: 1042266421     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2003.11.012     Document Type: Conference Paper

References (30)

1. Appel J.B., White F.J., Holohean A.M. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures. Neurosci Biobehav Rev. 6:1982;529-536.
2. Appel J.B., West W.B., Rolandi W.G., Alici T., Pechersky K. Increasing the selectivity of drug discrimination procedures. Pharmacol Biochem Behav. 64:1999;353-358.
3. Colpaert F.C., Janssen P.A.J. Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination. Arch Internat Pharmacodyn Ther. 258:1982;283-299.
4. Fiorella D., Rabin R.A., Winter J.C. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives. Psychopharmacol. 121:1995;357-363.
5. Colpaert F.C., Niemegeers C.J.E., Janssen P.A.J. A drug discrimination analysis of lysergic acid diethylamide LSD: in vivo agonist and antagonist effects of purported serotonin antagonists and of pirenperone, an LSD-antagonist. J Pharmacol Exp Ther. 221:1982;206-214.
6. Colpaert F.C., Meert T.F., Niemegeers C.J.E., Janssen P.A.J. Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat. Psychopharmacol. 86:1985;45-54.
7. 2 and DA antagonism on the stimulus properties of LSD. Soc Neurosci Abstr. 21:1995;1130.
8. Cunningham K.A., Appel J.B. Neuropharmacological reassessment of the discriminative stimulus properties of dlysergic acid diethylamide LSD. Psychopharmacol. 91:1987;67-73.
9. Burris K.D., Bredding M., Sanders-Bush E. (+) Lysergic Acid Diethylamide, but not its non-hallucinogenic congeners, is a potent serotonin 5-HT1C receptor agonist. J Pharmacol Exp Ther. 258:1991;891-896.
10. Appel J.B., Baker L.E., Barrett R.L., Broadbent J., Michael E.M., Riddle E.E., Van Groll B.J. Use of drug discrimination in drug abuse research. Glennon R.A., Järbe T.U.C., Frankenheim J. Drug discrimination: applications to drug abuse research. NIDA Res Monogr. 16:1991;369-398.
11. White F.J., Appel J.B. Training dose as a factor in LSD-saline discrimination. Psychopharmacol. 76:1982;20-25.
12. White F.J., Appel J.B. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. Science. 216:1982;535-537.
13. White F.J., Appel J.B. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride. J Pharmacol Exp Ther. 221:1982;421-427.
14. Järbe T.U.C., Swedberg M.D.B. Colpaert F.C., Slangen J.L. A conceptualization of drug discrimination learning. Drug discrimination: applications in CNS pharmacology. 1982;327-341 Elsevier, Amsterdam.
15. Swedberg M.D.B., Järbe T.U.C. Drug discrimination procedures: roles of relative stimulus control in two-drug cases. Psychopharmacol. 86:1985;444-451.
16. Callahan P.M., Appel J.B. Differentiation between the stimulus effects of LSD and lisuride using a three choice drug discrimination procedure. Psychopharmacology. 100:1990;131-138.
17. Swedberg M.D.B., Järbe T.U.C. Drug discrimination procedures: differential characteristics of the drug A vs. drug B and the drug A vs. drug B vs. no drug cases. Psychopharmacol. 90:1986;341-346.
18. White F.J. Comparative effects of LSD and lisuride, clues to specific hallucinogenic drug actions. Pharmacol Biochem Behav. 24:1986;365-379.
19. Overton D.A. Multiple drug training as a method for increasing the specificity of the drug discrimination procedure. J Pharmacol Exp Ther. 221:1982;166-172.
20. Palacios J.M., Waeber C., Hoyer D., Mengod G. Distribution of serotonin receptors. Ann NY Acad Science. 600:1990;36-52.
21. Deutch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neurosci. 46:1992;49-56.
22. Haigler H.J., Aghajanian G.K., Mescaline S.D. direct and indirect effects on serotonin-containing neurons in brain. Eur J Pharmacol. 21:1973;53-60.
23. Hirschhorn I.D., Hayes R.L., Rosecrans J.A. Discriminative control of behavior by electrical stimulation of the dorsal raphe nucleus: generalization to lysergic acid diethylamide (LSD). Brain Res. 86:1975;134-138.
24. Minnema D., Krynock G., Young R., Glennon R., Rosecrans J. LSD as a discriminative stimulus: role of dorsal raphe nucleus. Subst Alcohol Actions Misuse. 1:1980;29-34.
25. Waeber C., Palacios J.M. Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. Brain Res Mol Brain Res. 24:1994;199-209.
26. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev. 94:1987;469-472.
27. Nielsen E.B., Scheel-Kruger J. Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens. Eur J Pharmacol. 125:1986;85-92.
28. Glennon R.A., Titeler M., McKenney J.D. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35:1984;2505-2511.
29. Whitaker-Azmitia P.M. The discovery of serotonin and its role in neuroscience. Neuropsychopharmacol. 21:1999;2S-8S.
30. Jacobs B.L., Fornal C.A. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacol. 21:1999;9S-15S.